Literature DB >> 21081937

What is clinical utility and why should we care?

L J Lesko, I Zineh, S-M Huang.   

Abstract

Mesh：

Year:  2010        PMID： 21081937     DOI： 10.1038/clpt.2010.229

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  28 in total

1.  Genetics and cardiovascular disease: a policy statement from the American Heart Association.

Authors:  Euan A Ashley; Ray E Hershberger; Colleen Caleshu; Patrick T Ellinor; Joe G N Garcia; David M Herrington; Carolyn Y Ho; Julie A Johnson; Steven J Kittner; Calum A Macrae; Gia Mudd-Martin; Daniel J Rader; Dan M Roden; Derek Scholes; Frank W Sellke; Jeffrey A Towbin; Jennifer Van Eyk; Bradford B Worrall
Journal:  Circulation       Date:  2012-05-29       Impact factor: 29.690

2.  Pharmacogenetic testing: Current Evidence of Clinical Utility.

Authors:  Jivan Moaddeb; Susanne B Haga
Journal:  Ther Adv Drug Saf       Date:  2013-08-01

3.  Clinical implementation of genetic testing in medicine: a US regulatory science perspective.

Authors:  Lawrence J Lesko; Stephan Schmidt
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

4.  Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.

Authors:  Amy L Kaufman; Jared Spitz; Michael Jacobs; Matthew Sorrentino; Shennin Yuen; Keith Danahey; Donald Saner; Teri E Klein; Russ B Altman; Mark J Ratain; Peter H O'Donnell
Journal:  Mayo Clin Proc       Date:  2015-06       Impact factor: 7.616

Review 5.  The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?

Authors:  Mafalda M Dias; Michael J Sorich; Andrew Rowland; Michael D Wiese; Ross A McKinnon
Journal:  Pharm Res       Date:  2017-02-24       Impact factor: 4.200

Review 6.  The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.

Authors:  Ute I Schwarz; Markus Gulilat; Richard B Kim
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

7.  Reply to Bombard and Mighton.

Authors:  Daniele Carrieri; Heidi C Howard; Angus J Clarke; Vigdis Stefansdottir; Martina C Cornel; Carla G van El; Francesca Forzano
Journal:  Eur J Hum Genet       Date:  2019-01-18       Impact factor: 4.246

Review 8.  The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.

Authors:  P H O'Donnell; K Danahey; M J Ratain
Journal:  Clin Pharmacol Ther       Date:  2016-02-15       Impact factor: 6.875

9.  Single-Item Self-Report Measures of Team-Sport Athlete Wellbeing and Their Relationship With Training Load: A Systematic Review.

Authors:  Ciara Duignan; Cailbhe Doherty; Brian Caulfield; Catherine Blake
Journal:  J Athl Train       Date:  2020-09-01       Impact factor: 2.860

Review 10.  Comparison of delivery strategies for pharmacogenetic testing services.

Authors:  Susanne B Haga; Jivan Moaddeb
Journal:  Pharmacogenet Genomics       Date:  2014-03       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.